statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jubilant Pharmova zooms to 52-week high after US FDA classifies Roorkee facility as VAI

Experts hope to see the Nifty 50 at 22,600 in an immediate term and 22,800 in the short term, with support at 22,400, and then at 22,200. But, in between, the 22,500 level is likely to be crucial in determining the subsequent direction in the market

Experts line up top 10 buy ideas as D-St bulls charge Nifty towards 22,800 points

Around 70% of stocks in Nifty MidCap 100 and Nifty SmallCap 100 indices witnessed a rise in mutual fund stakes in December 2023 quarter, according to Ace Equities data.

MFs raise stakes in 70% Nifty smallcap, midcap stocks in Q3, despite caution

Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.

Jubilant Pharmova Ltd.

Watchers	94
52-Wk Low	311.90
52-Wk High	724.40

Volume	986,728.00
52-Wk High	724.40
52-Wk Low	311.90

Current Price	680.90
Prev Close	688.70
Open	694.25
Dividend Yield	1.79%
50-Day Moving Average	610.95
Beta	0.08
Avg. Volume	689,437.35
PE Ratio	285.57

52-Week High	724.40
52-Week Low	311.90
Market Capitalization	107.95B
EPS	2.37
Price to Book	2.00
Revenue Per Employee	13.23M
Enterprise Value/EBITDA	11.33

JUBLPHARMA.NSE Jubilant Pharmova Ltd.

About

Feed

News

Sentiment

Fundamentals